Secondary Hyperparathyroidism

Risk of Nonspinal Fracture Increased in Moderate to Severe CKD

Publish Date October 13, 2020

Fracture prevention efforts should be considered in patients with CKD of any age, according to investigators.

Post-Kidney Transplant Complication Rate Lower With PTx

Publish Date October 13, 2020

Parathyroidectomy prior to kidney transplantation is associated with a lower risk for severe postoperative complications compared with calcimimetic treatment, according to investigators.

Calcimimetic Resistance in SHPT Does Not Worsen Parathyroidectomy Outcomes

Publish Date October 5, 2020

Patients undergoing parathyroidectomy for SHPT that is refractory to calcimimetics frequently show significant enlargement of the parathyroid glands as well as histopathologic alterations, new findings suggest.

Possibly Safer Way to Correct Calcimimetic-Induced Hypocalcemia Reported

Publish Date October 1, 2020

In a study, investigators tested etelcalcetide combination therapies in patients on maintenance hemodialysis who have secondary hyperparathyroidism.

Cinacalcet, Paricalcitol Similarly Efficacious in Controlling PTH

Publish Date September 11, 2020

The selective vitamin D analog and calcimimetic were both beneficial in decreasing parathyroid hormone levels, according to the authors of a new meta-analysis.

Incorporating Calcimimetics Into Dialysis Payment Bundle Poses Challenges

Publish Date September 10, 2020

According to a study, 1 in 5 dialysis facilities might face financial losses if calcimimetics are included in the payment bundle, and providers may feel pressured to reduce calcimimetic use.

Cinacalcet Found Not to Reduce Death Risk

Publish Date September 9, 2020

The latest meta-analysis, however, confirms that the calcimimetic improves biochemical parameters, such as parathyroid hormone levels.

Comparative Effectiveness of Calcimimetics for Dialysis Patients

Publish Date August 27, 2020

Investigators analyzed data from 36 randomized trials comparing cinacalcet, etelcalcetide, and evocalcet with placebo.

Parathyroidectomy for Secondary vs Primary Hyperparathyroidism Costs More

Publish Date May 12, 2020

Hemodialysis patients with secondary hyperparathyroidism have higher rates of mortality, readmission, and reoperation than those with primary hyperparathyroidism, so parathyroidectomy is associated with higher costs, according to investigators.

Microwave Ablation Appears Effective for SHPT

Publish Date May 11, 2020

Parathyroid hormone levels declined in the 6 months after patients received microwave ablation, a meta-analysis finds.